Browsing by Author "Ross, Terry"
Now showing 1 - 6 of 6
Results Per Page
- ItemOpen AccessClinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae(BioMed Central, 2010-04-27) Chaubey, Vikas P.; Pitout, Johann D. D.; Dalton, Bruce; Ross, Terry; Church, Deirdre L.; Gregson, Daniel B.; Laupland, Kevin B.
- ItemOpen AccessThe distinct category of healthcare associated bloodstream infections(BioMed Central, 2012-04-09) Lenz, Ryan; Leal, Jenine R.; Church, Deirdre L.; Gregson, Daniel B.; Ross, Terry; Laupland, Kevin B.
- ItemOpen AccessExploring articulation capabilities in new technology ventures(2003) Ross, Terry; Hall, Jeremy
- ItemOpen AccessInnovation Agencies in a Resource Based Economy The Case of Alberta: Leadership, Energy, and Innovation(2017) Ross, Terry; Hawkins, Richard; Holbrook, Adam; DeWald, Jim; Mansell, Robert; Langford, Cooper; Fritzler, MarvinThere are government created organizations with a mandate to affect the sub- national system of innovation. These ‘innovation agency’ organizations provide functionality that enables additional innovation activity; this functionality may be delivered by organizations external to the innovation agency. The Alberta Oil Sands Science and Research Authority (AOSTRA), Alberta Heritage Foundation for Medical Research (AHFMR), and the Alberta Informatics Circle of Research Excellence (iCORE) are three innovation agencies that exemplify significant innovation policy investments by the Alberta government. This thesis uses historical analysis and case studies to examine these three innovation agencies. The historical analysis examines Alberta’s complex coevolution of institutions, policy leadership and technically challenging natural resources that set the stage for these innovation agencies to emerge. Case study techniques are used to explore the emergence, operations, and impact of the innovation agencies. The findings are then positioned in the system of innovation literature. It was found that the Alberta system of innovation was highly influenced by institutional control over natural resources and that the oil sands were particularly important, given their value and the scientific challenges that they presented. Peter Lougheed’s role in entrepreneurially shaping institutions was a contingency for the emergence of the cases. It was found that the innovation agencies generally acted to subsidize research activity in other organizations, although there were significant exceptions (e.g. AOSTRA’s IP policy and Underground Test Facilities). Finally, the instrumentality of the organizations was significant, leading to development and adoption of technological systems by industry and enhanced research capabilities at Alberta universities.
- ItemOpen AccessPopulation-Based Laboratory Surveillance of Imported Malaria in Metropolitan Calgary, 2000–2011(PLoS ONE, 2013-04-15) Lee, Clara S.; Gregson, Daniel B.; Church, Deirdre; Laupland, Kevin B.; Eckhardt, Rose; Ross, Terry; Chan, Wilson; Pillai, Dylan R.
- ItemOpen AccessThe Validation of a Novel Surveillance System for Monitoring Bloodstream Infections in the Calgary Zone(2016-06-07) Leal, Jenine R.; Gregson, Daniel B.; Church, Deirdre L.; Henderson, Elizabeth A.; Ross, Terry; Laupland, Kevin B.Background. Electronic surveillance systems (ESSs) that utilize existing information in databases are more efficient than conventional infection surveillance methods. The objective was to assess an ESS for bloodstream infections (BSIs) in the Calgary Zone for its agreement with traditional medical record review. Methods. The ESS was developed by linking related data from regional laboratory and hospital administrative databases and using set definitions for excluding contaminants and duplicate isolates. Infections were classified as hospital-acquired (HA), healthcare-associated community-onset (HCA), or community-acquired (CA). A random sample of patients from the ESS was then compared with independent medical record review. Results. Among the 308 patients selected for comparative review, the ESS identified 318 episodes of BSI of which 130 (40.9%) were CA, 98 (30.8%) were HCA, and 90 (28.3%) were HA. Medical record review identified 313 episodes of which 136 (43.4%) were CA, 97 (30.9%) were HCA, and 80 (25.6%) were HA. Episodes of BSI were concordant in 304 (97%) cases. Overall, there was 85.5% agreement between ESS and medical record review for the classification of where BSIs were acquired (kappa = 0.78, 95% Confidence Interval: 0.75–0.80). Conclusion. This novel ESS identified and classified BSIs with a high degree of accuracy. This system requires additional linkages with other related databases.